Comparison of the patients with CML with second cancers other than nonmelanoma skin cancers with the SEER data
| Variable* . | O . | E . | SIR (O/E) . | 95% CI for O/E . |
|---|---|---|---|---|
| Overall | 44 | 73 | 0.60 | 0.44-0.81 |
| Men | 30 | 45 | 0.67 | 0.45-0.95 |
| Women | 14 | 28 | 0.50 | 0.27-0.84 |
| Age ≥ 60 y | 23 | 34 | 0.68 | 0.43-1.01 |
| Age < 60 y | 21 | 40 | 0.53 | 0.32-0.80 |
| Second cancer type | ||||
| Prostate | 11 | 16 | 0.69 | 0.34-1.23 |
| Melanoma | 9 | 3 | 3 | 1.37-5.7 |
| Digestive system | 6 | 16 | 0.38 | 0.38-0.82 |
| Kidney | 3 | 2 | 1.5 | 0.31-4.38 |
| Endocrine | 3 | 0.1 | 30 | 6.18-87.60 |
| Breast | 2 | 8 | 0.24 | 0.03-0.86 |
| Variable* . | O . | E . | SIR (O/E) . | 95% CI for O/E . |
|---|---|---|---|---|
| Overall | 44 | 73 | 0.60 | 0.44-0.81 |
| Men | 30 | 45 | 0.67 | 0.45-0.95 |
| Women | 14 | 28 | 0.50 | 0.27-0.84 |
| Age ≥ 60 y | 23 | 34 | 0.68 | 0.43-1.01 |
| Age < 60 y | 21 | 40 | 0.53 | 0.32-0.80 |
| Second cancer type | ||||
| Prostate | 11 | 16 | 0.69 | 0.34-1.23 |
| Melanoma | 9 | 3 | 3 | 1.37-5.7 |
| Digestive system | 6 | 16 | 0.38 | 0.38-0.82 |
| Kidney | 3 | 2 | 1.5 | 0.31-4.38 |
| Endocrine | 3 | 0.1 | 30 | 6.18-87.60 |
| Breast | 2 | 8 | 0.24 | 0.03-0.86 |
Analysis conducted for the first invasive second cancers (second cancers other than nonmelanoma skin cancers).